Azitra, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| AZTR | SCNI | SNGX | FBIO | HIND | SBTX.L | |
|---|---|---|---|---|---|---|
| Market cap | 4.94M | 1.18M | 7.64M | 65.70M | 12.18M | 12.65M |
| P/E (TTM) | — | 0.0 | — | 0.7 | 1.0 | — |
| Forward P/E | -1.6 | — | -1.4 | -1.1 | — | 25.8 |
| Price/book | 0.7 | 0.0 | 1.1 | 0.4 | 2.0 | 1.6 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −81.33% | −95.76% | −72.66% | −21.83% | −70.33% | −70.00% |
| Today | −7.71% | −4.92% | −1.49% | +1.55% | −1.93% | −7.05% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All AZTR news ›Azitra, Inc. Advances ATR-04 Phase 1/2 Clinical Trial to Cohort 2 Following Safety Review Committee Clearance
BRANFORD, Conn., Oct. 1, 2026 /PRNewswire/ -- Azitra, Inc. (" Azitra " or the "Company") (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today…
Azitra, Inc. Announces Reverse Stock Split
Common Stock Will Begin Trading on a Split-Adjusted Basis on October 26, 2026 BRANFORD, Conn., Oct. 16, 2026 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative…
Azitra, Inc. Announces Revitalizing Results from Ex Vivo Study of ATR-COSF Demonstrating Ability to Reduce Fine Lines and Improve Elasticity in Human Skin
ATR-COSF uses a supernatant based formulation containing an active recombinant human domain of the protein, filaggrin. Ex vivo data in two models of recent cosmetic surgery explants showed visible improvements in fine lines, wrinkles and…
Azitra, Inc. announced that it has received $10.485 million in funding from Stonepine Capital Management LLC, Nantahala Capital Management, LLC and other investors.
On March 20, 2026, Azitra, Inc. closed the transaction. The company issued 10,485 Series A convertible non-redeemable preferred stock at an issue price of $1000 for gross proceeds of $10,485,000 and... On March 20, 2026, Azitra, Inc The…
Azitra Announces Breakthrough Repeat Dose And Anti-Wrinkle Ex Vivo Results For ATR-COSF Program
Published on 07/15/2026 at 11:35 am EDT Azitra announced promising results from two separate ex vivo human skin tissue studies. The studies evaluated the distribution and anti-wrinkle activity of Azitra's filaggrin domain containing…
Azitra, Inc. Auditor Raises 'Going Concern' Doubt
Azitra, Inc. filed its 10-K on Feb 27, 2026 for the period ending Dec 31, 2025. In this report its auditor, Grassi & Co., CPAs, P.C., gave an unqualified opinion expressing doubt that the company can... Biotechnology & Medical Research…
Azitra, Inc. (AZTR) Sets 1-for-10 Reverse Split Effective Oct. 26
TradingView Azitra, Inc. (AZTR) Sets 1-for-10 Reverse Split Effective Oct. 26 Azitra will implement a 1-for-10 reverse stock split effective 12:01 a.m. ET on Oct. 26, 2026; shares trade split-adjusted that day. Issued shares will dro
Azitra, Inc. (NYSEAMERICAN:AZTR) Stock Short Interest Declines 65.7%
Posted by Sarita Garza on Oct 15th, 2026 Shares of AZTR traded down $0.00 during trading hours on Wednesday, reaching $0.07. 2,670,554 shares of the company traded hands, compared to its average volume of 856,291. The stock’s fifty day…
Azitra, Inc. Expands Eligibility for ATR-04 Phase 1/2 Clinical Trial to Include Patients with Rashes due to KRAS and MEK Inhibitors
Expanded eligibility significantly broadens potential treatment opportunities for ATR-04 beyond EGFR inhibitor-associated skin rash Additional protocol modifications expected to facilitate patient recruitment and accelerate clinical trial…
Azitra, Inc.: Relative Strength Chart - Stock NYSE
Compare Azitra, Inc. with the company of your choice via a Relative Strength chart. Real-time AZTR price, NYSE stock exchange Relative Strength Chart Azitra, Inc. Biotechnology & Medical Research All financial news and data tailored to…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com4
- tradingview.com2
- ir.azitrainc.com1
- prnewswire.com1
- seekingalpha.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 11 articles, not a forecast.